Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-001817
Filing Date
2017-02-06
Accepted
2017-02-06 19:24:55
Documents
1
Period of Report
2017-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3804
  Complete submission text file 0001179110-17-001817.txt   5147
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Maynard Ryan D (Reporting) CIK: 0001363984 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 17576871